Position in OBIO
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$21,411,100
+$132,988 QoQ
Shares Held
5,037,906
-1.7% QoQ
Ownership
8.41%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in OBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $4,580,660,548 across 68 Biotechnology names. OBIO ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $655,974,329 | |
| 2 | CELC |
Celcuity Inc.
|
3,127,200 | $356,938,608 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,531,421 | $350,281,925 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
8,285,461 | $229,507,269 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
5,258,903 | $208,883,627 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,373,795 | $206,448,951 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
3,783,225 | $190,825,869 | |
| 8 | NUVL |
Nuvalent, Inc.
|
1,580,505 | $161,922,737 |
All Filings in OBIO
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,411,100 | 5,037,906 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $21,278,112 | 5,127,256 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,125,538 | 5,292,556 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,308,050 | 4,592,556 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,656,139 | 4,592,556 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $18,370,224 | 4,592,556 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,605,737 | 4,592,556 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,748,930 | 2,545,881 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $13,416,792 | 2,545,881 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $22,204,972 | 2,432,089 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $21,207,816 | 2,432,089 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,370,076 | 2,052,868 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $44,584,882 | 2,278,226 | Shares | Sole | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||